Home › Occupations › Molecular and Cellular Biologists › New Haven, CT
Molecular and Cellular Biologists in New Haven, CT: H-1B salaries
260 labor condition applications for this occupation with a work site in New Haven, CT. Median offered base salary $72,000; middle half $68,448–$76,500.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $67,800 |
| Level II (qualified) | $90,050 |
| Level III (experienced) | $73,381 |
| Level IV (fully competent) | $150,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Yale University | 236 | $70,554 |
| Alexion Pharmaceuticals, Inc. | 11 | $93,500 |
| Howard Hughes Medical Institute | 4 | $74,292 |
| Arjo Inc. | 2 | $90,000 |
| ExViva Inc | 2 | $125,000 |
| Bexorg, Inc. | 1 | $110,000 |
| Arvinas Operations, Inc. | 1 | $108,161 |
| Proteowise, Inc. | 1 | $72,000 |
| Yale New Haven Hospital | 1 | $77,278 |
| Empress Therapeutics, Inc. | 1 | $170,000 |
Job titles
- Associate Research Scientist149
- Postdoctoral Associate68
- Research Scientist8
- Postodctoral Associate6
- Instructor2
- Research Associate2
- Associate Scientist II, Biologic Drug Substance Development2
- Associate Scientist II, New Capabilities Process Dev2
- Associate Professor2
- Technical Solutions Manager2
- Chief Scientific Officer2
- Associate Scientist, Biologic Drug Substance Development1
- Research Speicalist1
- Associate Director, Injectables Drug Product Development1
- Assistant Professor/Research Scientist1
H-1B sponsors in New Haven, CT →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).